glp-1 grocery news Weight-Loss Drugs Are Changing What Americans Buy to Eat GLP-1 Medications Impact Food Spending

Needle phobia affects an estimated 20-30% of the adult population, and the logistics of cold-chain storage, injection site management, and weekly self-administration limit the reach of these therapies to a fraction of the eligible patient population

These effects are unlikely to arise from extensive systemic absorption

National regulatory guidance, payer policies, compliance standards, and large-scale claims review patterns inform this CPT 69210 analysis

Adv Ther 26(1):4054

A small observational study published in JCI Insight (2022) examined individuals with obesity receiving semaglutide who reported reductions in alcohol intake, though the relationship to weight loss requires further investigation in controlled trials